Cumberland Pharmaceuticals (CPIX) Short-Term Debt issuances: 2011-2024
Historic Short-Term Debt issuances for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Dec 2024 value amounting to $5.5 million.
- Cumberland Pharmaceuticals' Short-Term Debt issuances fell 28.57% to $5.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $38.5 million, marking a year-over-year increase of 22.28%. This contributed to the annual value of $38.5 million for FY2024, which is 22.28% up from last year.
- Latest data reveals that Cumberland Pharmaceuticals reported Short-Term Debt issuances of $5.5 million as of Q4 2024, which was down 49.95% from $11.0 million recorded in Q3 2024.
- Cumberland Pharmaceuticals' 5-year Short-Term Debt issuances high stood at $20.0 million for Q1 2022, and its period low was $5.5 million during Q4 2024.
- For the 3-year period, Cumberland Pharmaceuticals' Short-Term Debt issuances averaged around $10.2 million, with its median value being $8.0 million (2023).
- In the last 5 years, Cumberland Pharmaceuticals' Short-Term Debt issuances skyrocketed by 88.24% in 2021 and then plummeted by 60.00% in 2023.
- Cumberland Pharmaceuticals' Short-Term Debt issuances (Quarterly) stood at $15.0 million in 2020, then decreased by 6.67% to $14.0 million in 2021, then slumped by 55.71% to $6.2 million in 2022, then rose by 24.19% to $7.7 million in 2023, then decreased by 28.57% to $5.5 million in 2024.
- Its Short-Term Debt issuances stands at $5.5 million for Q4 2024, versus $11.0 million for Q3 2024 and $11.0 million for Q2 2024.